Metformin Lowers Serum Cobalamin without Changing Other Markers of Cobalamin Status: A Study on Women with Polycystic Ovary Syndrome

Treatment with the anti-diabetic drug metformin is followed by a decline in plasma cobalamin, but it is unsettled whether this denotes an impaired cobalamin status. This study has explored changes in the markers of cobalamin status in women with Polycystic Ovary Syndrome treated with metformin (1.5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Greibe, Eva, Trolle, Birgitta, Bor, Mustafa V., Lauszus, Finn F., Nexo, Ebba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738982/
https://www.ncbi.nlm.nih.gov/pubmed/23857221
http://dx.doi.org/10.3390/nu5072475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738982/
https://www.ncbi.nlm.nih.gov/pubmed/23857221
http://dx.doi.org/10.3390/nu5072475

Ejemplares similares